BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7004631)

  • 1. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB; Fontana JA
    Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
    Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
    Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth medium for the evaluation of antiestrogenic compounds in MCF-7 cell culture.
    Jain PT; Pento JT
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):595-8. PubMed ID: 1787766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
    Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
    J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Hu XF; DeLuise M; Zalcberg JR
    Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth control of human mammary cancer cells (MCF-7 cells) in culture: effect of estradiol and growth factors in serum-containing medium.
    Aakvaag A; Utaaker E; Thorsen T; Lea OA; Lahooti H
    Cancer Res; 1990 Dec; 50(24):7806-10. PubMed ID: 2253223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line.
    Devleeschouwer N; Body JJ; Legros N; Muquardt C; Donnay I; Wouters P; Leclercq G
    Anticancer Res; 1992; 12(3):789-94. PubMed ID: 1622138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.